First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial Yelena Y. Janjigian , Kohei Shitara , Markus Moehler +26 more 2021 The Lancet 2580 citations
Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing Xinyi Guo , Yuanyuan Zhang , Liangtao Zheng +16 more 2018 Nature Medicine 1675 citations
Mutational hot spot in the p53 gene in human hepatocellular carcinomas Ih‐Chang Hsu , Robert A. Metcalf , Tai‐ping Sun +3 more 1991 Nature 1530 citations
Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries Hongmei Zeng , Wanqing Chen , Rongshou Zheng +41 more 2018 The Lancet Global Health 1487 citations
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial Edward S. Kim , Vera Hirsh , Tony Mok +15 more 2008 The Lancet 1240 citations